Market Research Logo

Europe Market Report for Transcervical Female Sterilization 2017 - MedCore

Europe Market Report for Transcervical Female Sterilization 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® procedure. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. The United Kingdom was the last country to approve the Essure® procedure in Europe, with NICE granting approval in 2009. Since the Essure® procedure entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.

Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.


EXECUTIVE SUMMARY
EUROPE LAPAROSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Gynecological Conditions
2.1.1.1 Gynecological Cancers
2.1.1.2 Uterine Fibroids
2.1.1.3 Endometriosis
2.1.1.4 Menorrhagia
2.1.1.5 Pelvic Prolapse
2.1.1.6 Ectopic Pregnancy
2.1.1.7 Hysterectomy
2.1.2 Digestive Tract Conditions
2.1.2.1 Stomach Cancer
2.1.2.2 Hernia
2.1.2.3 Gallbladder Attack
2.1.2.4 Obesity
2.1.3 Colorectal Conditions
2.1.3.1 Colorectal Cancer
2.1.3.2 Inflammatory Bowel Disease
2.1.3.3 Diverticulitis
COUNTRY PROFILES
3.1 INTRODUCTION
3.1.1.1 Population
3.1.1.2 Median Age
3.1.1.3 GDP Per Capita
3.1.1.4 Price Index
3.2 GERMANY
3.3 FRANCE
3.4 UNITED KINGDOM
3.5 ITALY
3.6 SPAIN
3.7 BENELUX
3.8 SCANDINAVIA
3.9 AUSTRIA
3.10 SWITZERLAND
3.11 PORTUGAL
TRANSCERVICAL FEMALE STERILIZATION MARKET
4.1 INTRODUCTION
4.1.1 Tubal Ligation
4.1.2 Mechanical Sterilization
4.1.3 Bipolar Electrocoagulation
4.1.4 Transcervical Implant
4.2 MARKET ANALYSIS AND FORECAST
4.3 DRIVERS AND LIMITERS
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Laparoscopic Devices Market by Segment, Europe, 2013 – 2023
Chart 1 2: Laparoscopic Devices Market Overview, Europe, 2016 & 2023
Chart 3 1: Country Profile, Germany, 2016
Chart 3 2: Country Profile, France, 2016
Chart 3 3: Country Profile, United Kingdom, 2016
Chart 3 4: Country Profile, Italy, 2016
Chart 3 5: Country Profile, Spain, 2016
Chart 3 6: Country Profile, Benelux, 2016
Chart 3 7: Country Profile, Scandinavia, 2016
Chart 3 8: Country Profile, Austria, 2016
Chart 3 9: Country Profile, Switzerland, 2016
Chart 3 10: Country Profile, Portugal, 2016
Chart 4 1: Transcervical Female Sterilization Market, Europe, 2013 – 2023
Chart 4 2: Leading Competitors, Transcervical Female Sterilization Market, Europe, 2016
List of Figures
Figure 1 1: Laparoscopic Device Market Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Laparoscopic Device Market Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Laparoscopic Device Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Laparoscopic Device Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Laparoscopic Device Market, Europe, 2014 – 2017
Figure 1 7: Laparoscopic Device Markets Covered, Europe, 2016
Figure 1 8: Laparoscopic Device Markets Covered, Europe, 2016 (1 of 2)
Figure 1 9: Laparoscopic Device Markets Covered, Europe, 2016 (2 of 2)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 4 1: Transcervical Female Sterilization Market, Europe, 2013 – 2023 (€and US$)
Figure 4 2: Units Sold by Country, Transcervical Female Sterilization Market, Europe, 2013-2023
Figure 4 3: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2013-2023 (€)
Figure 4 4: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2013-2023 (US$)
Figure 4 5: Transcervical Female Sterilization Market by Country, Europe, 2013-2023 (€M)
Figure 4 6: Transcervical Female Sterilization Market by Country, Europe, 2013-2023 (US$M)
Figure 4 7: Drivers and Limiters, Transcervical Female Sterilization Market, Europe, 2016
Figure 4 8: Leading Competitors by Country, Transcervical Female Sterilization Market, Europe, 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report